Opportunity Screening for Early Detection of Gestational Diabetes: Results from the MERGD Study
Authors:
- Manju MamtaniMMManju Mamtani
- Kunal KurheKKKunal Kurhe
- Ashwini PatelAPAshwini Patel
- Manisha JaisinghaniMJManisha Jaisinghani
- Kanchan V. PipalKPKanchan V. Pipal
- Savita BhargavSBSavita Bhargav
- Shailendra MundhadaSMShailendra Mundhada
- Prabir Kumar DasPDPrabir Kumar Das
- Seema ParvekarSPSeema Parvekar
- Vaishali KhedikarVKVaishali Khedikar
- Archana B. PatelAPArchana B. Patel
- Hemant KulkarniHKHemant Kulkarni
Open Access
- 10 October 2025
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (20) , 7151
Abstract
Background: The definitions and approaches used to diagnose gestational diabetes (GD) are varied. The two-step approach recommended by the American College of Obstetricians and Gynecologists (ACOG) combines the sensitivity of a glucose challenge test (GCT) with the specificity of a 3-hour oral glucose tolerance test (OGTT). We investigated if minor modification of the two-step procedure can provide improved detection of GD by identifying a risk group of pregnant women with high risk of GD. Methods: We conducted a prospective cohort study of pregnant women enrolled early during pregnancy and followed till delivery. All participants underwent the ACOG-recommended two-step procedure for GD diagnosis. Based on GCT and OGTT results, the participants were divided into four risk groups (RGs): GCT-negative (RG0), GCT-positive but OGTT normal (RG1), single abnormal value on OGTT or raised HbA1c (RG2) and diagnosed GD (RG3). Baseline evaluation included dietary history (24 hour recall) and physical activity. A series of multivariable logistic regression analyses were conducted to estimate the odds of maternal and fetal outcomes. Results: A total of 1041 pregnant women were included in the study, of whom 16 (1.6%) were diagnosed as GD. Our two-step approach identified 48 (4.6%) women as GD, while RG2, RG1 and RG0 comprised 75 (7.2%), 218 (20.9%) and 700 (67.2%), respectively. Compared to RG0, RG2 showed a higher likelihood of antepartum complications [odds ratio and 95% confidence interval 2.38 (1.16–4.15)], any adverse outcome without [2.04 (1.17–3.55)] or with cesarean section [2.09 (1.21–3.61)] and primary cesarean section [1.68 (1.01–2.81)] after adjustment for potential confounders. RG2 was also significantly associated with pregnancy-induced hypertension, meconium-stained amniotic fluid and premature rupture of membranes. Conclusions: In the study participants, we identified a subgroup (RG2) at high risk of GD with perinatal outcomes showing profile consistent with that of GD.Keywords
All Related Versions
Funding Information
- Lata Medical Research Foundation, Nagpur, India (Intramural)
This publication has 44 references indexed in Scilit:
- One-step vs 2-step gestational diabetes mellitus screening and pregnancy outcomes: an updated systematic review and meta-analysisAmerican Journal of Obstetrics & Gynecology MFM, 2024
- Prediction of gestational diabetes mellitus and perinatal outcomes by plasma zonulin levelsArchives of Gynecology and Obstetrics, 2022
- Screening for Gestational DiabetesJAMA, 2021
- Prediction of adverse neonatal outcome among newborns born through meconium‐stained amniotic fluidInternational Journal of Gynecology & Obstetrics, 2021
- Screening and diagnosis of gestational diabetes in India: a systematic review and meta-analysisActa Diabetologica, 2018
- Application of One-Step IADPSG Versus Two-Step Diagnostic Criteria for Gestational Diabetes in the Real World: Impact on Health Services, Clinical Care, and OutcomesCurrent Diabetes Reports, 2017
- Single abnormal value on 3-hour oral glucose tolerance test during pregnancy is associated with adverse maternal and neonatal outcomes: a systematic review and metaanalysisAmerican Journal of Obstetrics and Gynecology, 2016
- The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study: paving the way for new diagnostic criteria for gestational diabetes mellitusAmerican Journal of Obstetrics and Gynecology, 2010
- Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infantsEuropean Journal of Clinical Pharmacology, 2009
- Criteria for screening tests for gestational diabetesAmerican Journal of Obstetrics and Gynecology, 1982